0001209191-23-032276.txt : 20230525
0001209191-23-032276.hdr.sgml : 20230525
20230525183732
ACCESSION NUMBER: 0001209191-23-032276
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230524
FILED AS OF DATE: 20230525
DATE AS OF CHANGE: 20230525
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kersten Dirk
CENTRAL INDEX KEY: 0001823682
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39509
FILM NUMBER: 23962461
MAIL ADDRESS:
STREET 1: C/O FORBION CAPITAL FUND IV COOPERATIEF
STREET 2: GOOMIER 2-35
CITY: NAARDEN
STATE: P7
ZIP: 14111 DC
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dyne Therapeutics, Inc.
CENTRAL INDEX KEY: 0001818794
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 364883909
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1560 TRAPELO ROAD
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (781) 786-8230
MAIL ADDRESS:
STREET 1: 1560 TRAPELO ROAD
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-05-24
0
0001818794
Dyne Therapeutics, Inc.
DYN
0001823682
Kersten Dirk
C/O DYNE THERAPEUTICS, INC.
1560 TRAPELO ROAD
WALTHAM
MA
02451
1
0
1
0
0
Stock Option (right to buy)
13.49
2023-05-24
4
A
0
24900
0.00
A
2033-05-23
Common Stock
24900
24900
D
This option was granted on May 24, 2023. The shares underlying the option are scheduled to vest in full on the earlier of (i) May 24, 2024 or (ii) the date of the Issuer's 2024 Annual Meeting of Stockholders.
/s/ Richard Scalzo, Attorney-in-Fact
2023-05-25